Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Bioinformatics Services Market

Bioinformatics Services Market Trends

  • Report ID: GMI6926
  • Published Date: Oct 2023
  • Report Format: PDF

Bioinformatics Services Market Trends

  • Government fundings and collaborative research initiatives have emerged as crucial drivers for the market. For instance, in 2019, NIH granted approximately USD 29.5 million funds for advancing sequencing and bioinformatics technology for human genome.
  • Similarly, in 2019, the Rockefeller Foundation announced over USD 20 million in funding and several non-financial collaborations to help strengthen global capabilities in genomic sequencing & data sharing.

These investments provided essential resources for researchers and companies, thereby aiding in market growth. Moreover, collaborative efforts among academic institutions, research organizations, and industry players have also intensified, leading to the creation of diverse datasets and the need for bioinformatics services to analyse and interpret these data.

  • Furthermore, the increasing demand for precision medicine is a significant driver for the market.
  • For instance, 12 new drugs identified as personalized medicines were approved in 2022 by FDA, which represented about 34% of all newly approved drugs. Personalized medicine relies on the analysis of an individual's genetic makeup to tailor medical treatments and therapies.

As this approach gains prominence in healthcare, bioinformatics plays a pivotal role in deciphering genetic data to guide treatment decisions. Thus, increasing focus on personalized medicine is expected to continue driving the market demand.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global bioinformatics services industry was valued at USD 2.8 billion in 2022 and is anticipated to reach USD 12 billion by 2032, primarily driven by rapid advancements in genomic sequencing technologies.

The genomics segment is anticipated to reach USD 4.6 billion by 2032, attributed to increased availability of genomic data, advancements in sequencing technologies, and a growing awareness of the potential applications of genomics in healthcare.

North America bioinformatics services industry held a revenue share of 45.5% in 2022, attributed to robust investment in R&D, strong emphasis on personalized medicine, substantial fundings to support drug discovery, disease diagnosis, and genomic research.

Illumina, Inc., BGI, Thermo Fisher Scientific Inc., PerkinElmer Inc., Eurofins Scientific, NeoGenomics, CD Genomics, Macrogen, QIAGEN (QIAGEN N.V.), GENEWIZ, and Source BioScience among others.

Bioinformatics Services Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 221
  • Countries covered: 19
  • Pages: 180
 Download Free Sample